Jad Fakhry, 10% Owner at NovaBay Pharmaceuticals, Inc. (NBY), bought 28,731 shares at $0.47 ($16K) on 2025-04-08, disclosed to the SEC on 2025-04-15.
Open-market purchase of $16k NBY by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.58 | 917 | $532 | 3.3% |
| 2 | $0.56 | 22,976 | $13K | 80.9% |
| 3 | $0.52 | 4,538 | $2K | 14.8% |
| 4 | $0.47 | 300 | $141 | 0.9% |
| Total | $0.55 avg | 28,731 | $16K | 100% |
| Filing → |
| NBY | BUY | 2025-04-15 | $31K | — | Filing → |
| SWSH | BUY | 2016-05-17 | $97K | — | Filing → |